MariMed Shares are Booming Despite Sideways Movement in the Marijuana Index
MariMed Inc (OTCQB:MRMD): MariMed shares are gaining positive momentum since the start of this year albeit sideways movement in the marijuana index. The North American marijuana index remains range-bound over the last two months after …
ObsEva SA Reaches Clinical Trial Endpoint – Shares Jump +25%
The Swiss-based biotechnology company ObsEva SA (NASDAQ:OBSV) has announced that it has reached the endpoints of its clinical trial with shares jumping over 25% after the announcement was made.
The company, which focuses …
Verastem Inc. Announces Stock Offering to Consonance Capital – Share Rise +15%
Massachusetts-based biopharmaceutical company Verastem Inc. (NASDAQ:VSTM) announced on Thursday that it would be offering approximately seven million shares of the company’s common stock to Consonance Capital (private).
Shares of the company rose over …
Galmed Pharmaceuticals Shares Surge Nearly 150% After Phase 2B Study
Shares of the Israeli biotechnology company Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) surged nearly 150% on Tuesday after the company released its results on the Phase 2B ARREST study.
The study was meant to focus …
Vical Inc. Reports Failed Phase 2 Trial of Herpes Vaccine
California-based biotechnology company Vical Incorporated (NASDAQ:VICL) released, on Monday, the results of its Phase 2 herpes simplex virus-2 (HSV-2) therapeutic vaccine.
Unfortunately, the trial failed to meet its primary endpoint, so the company …
Scythian Biosciences Announces Name Change to SOL Global Investments Corp.
TORONTO, June 05, 2018 (GLOBE NEWSWIRE) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (OTC:SCCYF) (FRA: 9SB) is pleased to announce that the Company will be changing its name from “Scythian Biosciences Corp.” to …
Axovant Sciences – Completes Company Reorganization for Pipeline Expansion
UK-based biotechnology company Axovant Sciences Ltd (NASDAQ:AXON) has completed the reorganization and strengthening of its management team in preparation for the company’s pipeline expansion.
Axovant Sciences has announced that Gavin Corcoran will be …
ContraVir Pharmaceuticals Announces Reverse Stock Split
New Jersey-based biotechnology company ContraVir Pharmaceuticals (NASDAQ:CTRV) announced on Thursday that it will be having a reverse split of its common stock.
A reverse stock split is meant to help a company to …
Cara Therapeutics Enters into Agreement With Vifor Fresenius
Connecticut-based biotechnology company Cara Therapeutics (NASDAQ:CARA) has announced that it has entered into an agreement with Vifor Fresenius Medical Care Renal Pharma Ltd. on Wednesday.
Vifor Fresenius, a joint company from Vifor Pharma …
BioDelivery Sciences International Announces Agreement with Broadfin Capital
Shares of the North Carolina-based biotechnology company BioDelivery Sciences International (NASDAQ:BDSI) jumped after the company announced that they had entered an agreement with Broadfin Capital LLC (private).
The agreement is meant to help …